taraxerol has been researched along with Cognitive Dysfunction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berté, TE; Bürger, C; Cechinel-Filho, V; Dalmagro, AP; de Souza, MM; Dos Santos, DA; Gonçalves, AE; Meyre-Silva, C; Weber, CJ; Zimath, PL | 1 |
1 other study(ies) available for taraxerol and Cognitive Dysfunction
| Article | Year |
|---|---|
Taraxerol as a possible therapeutic agent on memory impairments and Alzheimer's disease: Effects against scopolamine and streptozotocin-induced cognitive dysfunctions.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Avoidance Learning; Cognitive Dysfunction; Male; Maze Learning; Memory; Oleanolic Acid; Rats; Rats, Wistar; Scopolamine; Streptozocin | 2018 |